Clindamycin Injection USP in 5% Dextrose: recall status
⚠ Recalls found. Clindamycin Injection USP in 5% Dextrose is named in 4 official recalls in our current data:
- Brand
- Baxter Healthcare
Recalls naming this model
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0808-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0815-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0817-2026 ·
Official record ↗
FDA Class II · Drug · September 9, 2026
CGMP Deviations
Company / brand: Baxter Healthcare recalls
Affected product: Clindamycin Injection USP in 5% Dextrose recall status
Official ID D-0818-2026 ·
Official record ↗
See all Baxter Healthcare recalls →
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.